MGRM Insider Transactions: Directors’ Stock Options Filed May 21, 2026

Insider trading filings reveal what company leaders really think about their stock. When directors file initial ownership disclosures, it signals their commitment to the company. Two directors at MGRM (Monogram Orthopaedics, Inc.) recently disclosed significant stock option holdings. These Form 3 filings show directors Gray Colleen and Van Kirk Richard Lee Jr holding options to acquire a combined 5,000 shares. The filings provide a snapshot of leadership’s equity stake in the orthopedic device maker.

Gray Colleen’s Director Option Holdings

Director Gray Colleen filed an initial ownership disclosure on October 14, 2025. The filing revealed options to acquire 3,000 shares of common stock at $4.00 per share, valued at $12,000. This Form 3 filing represents Colleen’s first reported equity stake in the company.

The options carry a future exercise date of November 30, 2030. This extended timeline suggests these are long-term incentive grants designed to align leadership with shareholder interests. Colleen’s substantial option position indicates confidence in MGRM’s future performance.

Van Kirk Richard Lee Jr’s Option Position

Director Van Kirk Richard Lee Jr filed his initial ownership disclosure on September 30, 2025. His SEC filing disclosed options to acquire 2,000 shares at $2.00 per share, totaling $4,000. Like Colleen’s filing, this Form 3 represents his first reported equity ownership in MGRM.

Lee’s options vest on July 31, 2027, providing a shorter timeline than Colleen’s grant. The lower strike price of $2.00 suggests these options may have been granted at different times or under different compensation structures. Combined with Colleen’s holdings, director equity stakes now total 5,000 option shares.

What Form 3 Filings Mean for Investors

Form 3 filings are initial ownership reports required when insiders first acquire securities. These filings establish a baseline for tracking future insider activity. Both directors’ filings show option holdings rather than direct stock purchases, which is typical for executive compensation.

The timing of these disclosures in fall 2025 suggests both directors received equity grants around the same period. This coordinated compensation approach is common for board members joining or formalizing their equity stakes. Investors can use these filings to monitor whether directors exercise their options or acquire additional shares.

Understanding MGRM’s Insider Equity Strategy

Monogram Orthopaedics uses stock options as a key tool to retain and motivate board leadership. The combined 5,000 option shares represent meaningful equity exposure for both directors. With MGRM’s market cap at $243.8 million, these holdings align director interests with long-term shareholder value.

Meyka AI rates MGRM a grade of B, reflecting solid fundamentals and sector positioning. Director equity stakes like these reinforce management confidence in the company’s strategic direction. Investors should monitor future Form 4 filings to track whether these options get exercised or if additional insider transactions occur.

Final Thoughts

Two MGRM directors disclosed significant stock option holdings through Form 3 filings in fall 2025. Gray Colleen holds 3,000 options at $4.00 per share, while Van Kirk Richard Lee Jr holds 2,000 options at $2.00 per share. These initial ownership disclosures establish a baseline for tracking insider activity at Monogram Orthopaedics. The coordinated equity grants signal leadership confidence in the orthopedic device maker’s future. Investors should monitor Form 4 filings for any exercise or disposition activity from these directors.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.